Xiao J et al., 2023-02-17: Chinese randomized controlled trial in 172 stage II-III rectal cancer patients: methylene blue injected into the inferior mesenteric artery before dissection significantly increased lymph-node harvest, mainly by increasing retrieval of mini nodes (2 mm or less).
From May 2020 to May 2022, 172 stage II-III rectal cancer patients were randomized to methylene blue (MB) stained group or unstained group to retrieve the lymph nodes.
48
Xiao J et al., 2023-02-17: Chinese randomized controlled trial in 172 stage II-III rectal cancer patients: methylene blue injected into the inferior mesenteric artery before dissection significantly increased lymph-node harvest, mainly by increasing retrieval of mini nodes (2 mm or less). C2 China (Sichuan). Study type: randomized controlled trial, N=172. Route: methylene blue solution injected into the inferior mesenteric artery; dose/concentration not in abstract. Comparator: unstained group. Funder: Department of Science and Technology of Sichuan Province (grant 2021YFS0025) per the record's grant list. Conflicts: none declared. Journal Int J Colorectal Dis 38(1):48. English-language report of a Chinese trial. Study type: randomized trial.
